TR200100444T2 - Paroksetin Hidroklorid'in bir kristalin olmayan anhidrat formunun hazırlanma yöntemi - Google Patents

Paroksetin Hidroklorid'in bir kristalin olmayan anhidrat formunun hazırlanma yöntemi

Info

Publication number
TR200100444T2
TR200100444T2 TR2001/00444T TR200100444T TR200100444T2 TR 200100444 T2 TR200100444 T2 TR 200100444T2 TR 2001/00444 T TR2001/00444 T TR 2001/00444T TR 200100444 T TR200100444 T TR 200100444T TR 200100444 T2 TR200100444 T2 TR 200100444T2
Authority
TR
Turkey
Prior art keywords
paroxetine hydrochloride
preparation
anhydrate form
crystalline anhydrate
propan
Prior art date
Application number
TR2001/00444T
Other languages
English (en)
Inventor
Witold Jacewicz Victor
Ward Neal
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817196.0A external-priority patent/GB9817196D0/en
Priority claimed from GBGB9828777.4A external-priority patent/GB9828777D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200100444T2 publication Critical patent/TR200100444T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Propan-2-ol un çikartilmasi için paroksetin hidroklorid propan-2-ol-solvat desolvatlanir ve paroksetin hidroklorid anhidrat, solvat kitlesi isitilarak ve bu solvat kitlesindeki propan-2-ol miktari azaldikça isitma sicakligi artirilarak hazirlanir.
TR2001/00444T 1998-08-07 1999-08-06 Paroksetin Hidroklorid'in bir kristalin olmayan anhidrat formunun hazırlanma yöntemi TR200100444T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9817196.0A GB9817196D0 (en) 1998-08-07 1998-08-07 Novel process
GBGB9828777.4A GB9828777D0 (en) 1998-12-29 1998-12-29 Novel compounds

Publications (1)

Publication Number Publication Date
TR200100444T2 true TR200100444T2 (tr) 2001-07-23

Family

ID=26314179

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00444T TR200100444T2 (tr) 1998-08-07 1999-08-06 Paroksetin Hidroklorid'in bir kristalin olmayan anhidrat formunun hazırlanma yöntemi

Country Status (24)

Country Link
EP (2) EP1321465A3 (tr)
JP (1) JP2002522434A (tr)
KR (1) KR20010072323A (tr)
CN (1) CN1321155A (tr)
AP (2) AP2001002072A0 (tr)
AT (1) ATE239016T1 (tr)
AU (1) AU5428999A (tr)
BG (1) BG105310A (tr)
BR (1) BR9912858A (tr)
CA (1) CA2339857A1 (tr)
DE (1) DE69907467T2 (tr)
DK (1) DK1100796T3 (tr)
EA (1) EA200100221A1 (tr)
ES (1) ES2198940T3 (tr)
HK (1) HK1038230A1 (tr)
HU (1) HUP0105466A3 (tr)
ID (1) ID27914A (tr)
IL (1) IL141286A0 (tr)
NO (1) NO20010629L (tr)
PL (1) PL345885A1 (tr)
PT (1) PT1100796E (tr)
SK (1) SK1972001A3 (tr)
TR (1) TR200100444T2 (tr)
WO (1) WO2000008017A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384720A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Process for drying paroxetine hydrochloride
JP3796351B2 (ja) 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
ES2311561T3 (es) * 2000-11-17 2009-02-16 Eli Lilly And Company Dipeptido de lactama y su uso en la inhibicion de la liberacion del peptido beta amiloide.
EP2596792A1 (en) 2002-10-16 2013-05-29 Takeda Pharmaceutical Company Limited Stable solid preparations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
HUP0000960A3 (en) * 1997-01-15 2001-04-28 Smithkline Beecham Plc Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法

Also Published As

Publication number Publication date
WO2000008017A1 (en) 2000-02-17
EP1100796A1 (en) 2001-05-23
HUP0105466A2 (hu) 2002-05-29
PL345885A1 (en) 2002-01-14
EP1321465A3 (en) 2003-09-03
JP2002522434A (ja) 2002-07-23
AU5428999A (en) 2000-02-28
ES2198940T3 (es) 2004-02-01
KR20010072323A (ko) 2001-07-31
CN1321155A (zh) 2001-11-07
NO20010629D0 (no) 2001-02-06
DE69907467D1 (de) 2003-06-05
EP1100796B1 (en) 2003-05-02
ATE239016T1 (de) 2003-05-15
PT1100796E (pt) 2003-09-30
EA200100221A1 (ru) 2001-08-27
EP1321465A2 (en) 2003-06-25
HK1038230A1 (en) 2002-03-08
SK1972001A3 (en) 2001-08-06
HUP0105466A3 (en) 2002-11-28
CA2339857A1 (en) 2000-02-17
AP0102072A0 (en) 2001-02-06
BG105310A (en) 2001-12-29
BR9912858A (pt) 2001-11-20
AP2001002072A0 (en) 2001-03-31
IL141286A0 (en) 2002-03-10
ID27914A (id) 2001-05-03
NO20010629L (no) 2001-03-20
DE69907467T2 (de) 2004-03-11
DK1100796T3 (da) 2003-08-25

Similar Documents

Publication Publication Date Title
TR200102800T2 (tr) Yeni bileşikler.
BR0010704A (pt) Composições e métodos de anti-náusea
TR199700470A2 (tr) Sildenafilin hazirlanmasi için proses.
AR023188A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonan-4-carboxilatos y carboxamidas, su preparacion y su aplicacion en terapeutica
TR199800011T1 (tr) Benzo[g] kuinolin türevleri
SE9702773D0 (sv) Novel compounds
ATE347600T1 (de) Gruppe b-streptococcus antigene
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
TR199801866A1 (tr) Yeni piperazin ve piperidin bilesikleri
TR199700206A2 (tr) Floralkil- ve floralkoksi ikame edilmis heterosiklik bradikinin-antagonistleri, bunlarin imal edilmesine mahsus usul ve bunlarin kullanilmalari.
TR200100444T2 (tr) Paroksetin Hidroklorid'in bir kristalin olmayan anhidrat formunun hazırlanma yöntemi
DE69627702D1 (de) Stabilisierte, korrosionsinhibierte feuerhemmende zusammensetzungen und methoden
DE60006825D1 (de) Serotonerge benzofurane
DE60022048D1 (de) Turbinenkraftstoffzusammensetzung
TR200202195T2 (tr) 5-Yer değiştirmiş 1-(4-florofenil)-1,3- dihidroizobenzofuran'ın adım adım alkillenmesi
PH22537A (en) 3-aminocarbonylmethoxy-5-phenylpyrazole compounds and anti-arrythmic compositions containing them
DK0992512T3 (da) Reduceret cortisolkonjugat
BG34610A3 (en) Method for preparating 2', 6'- dialkyl- n- (alkoxymethyl)- 2- chloracetanylides
MX9603199A (es) Antagonistas de receptores a endotelina.
PA8524001A1 (es) Proceso para preparar 2-(4-piridil)amino-6-dialquiloxifenil-pirido (2,3-d) pirimidin-7-onas
DK1104419T3 (da) N-substituerede azabicyloheptan-derivater, deres fremstilling og anvendelse
IT1304846B1 (it) Composizione ecologica autoestinguente per la realizzazione di formeplastiche, stucchi, pannelli e simili.
NO20014937L (no) Naturlige pseudomycinprodukter
DE69909273D1 (de) Phosphat-vermittelte cyclisierung
DK1131273T3 (da) 1,4-Diaryl-2-fluor-1-buten-3-olforbindelser og deres anvendelse til fremstilling af 1,4-diaryl-2-fluor-1,3-butadien- og 1,4-diaryl-2-fluor-2-butenforbindelser